Products such as cannabidiol (CBD) have lately improved in appeal over the past decades, being associated with anti-inflammatory and anti-oxidant effects.CBD is a significant non-intoxicating cannabis component with abundance in popular cannabis stress. Lately, there have been inventions of another prospective therapeutic non-intoxicating cannabinoid item.
Cannabigerol (CBG) is proved to be a less plentiful cannabinoid and is associated with reducing pain, lowering swelling, and slowing the rate of spreading a few cancer cells.CBG seems to have some similarities …
New Framework for Regulating Psilocybin
(MORA)Memorandum of Regulatory Approval is a detailed report whose objective is to offer the Canadian lawmakers a new framework where they can amend the existing psychedelics, especially psilocybin laws. These laws revolve around the therapeutic drug, especially for palliative care and end-of-life patients.
The new framework act as a reference tool for the Canadian government to draft laws to allow medical specialists accesses the psilocybin treatment for the palliative patients. This is the best way to ensure that patients with severe conditions and close to end…
Difference between Psilocybin and LSD
Let’s explore the difference between psilocybin and LSD in magic mushrooms and understand their similarities. These compounds have psychoactive features, which are categorized in the psychedelics family. They can work together with the 5-HT2A receptors to induce mood, behavior, personality, and cognition changes.
Psilocybin is the main psychoactive element in psilocybin mushrooms, whose application exceeds the written human history. In other words, psilocybin is a prodrug, a substance metabolized by the body into an approved active drug. Through the human …